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OBJECTIVE—Hepatocyte nuclear factor 1 (HNF1)i sa
transcription factor that is critical for pancreatic cell forma-
tion and glucose homeostasis. Previous studies have reported
that common variants of HNF1 were associated with type 2
diabetes in Caucasians and West Africans. However, analysis
in the subjects from the Botnia study and Malmo ¨ Preventive
Project produced conﬂicting results, and the role for HNF1
in type 2 diabetes susceptibility remains unclear. We therefore
investigated common variants across the HNF1 gene in a
Chinese population.
RESEARCH DESIGN AND METHODS—Fifteen tagging single
nucleotide polymorphisms (SNPs) were analyzed for association
with type 2 diabetes in subjects with type 2 diabetes (n  1,859)
and normal glucose regulation (n  1,785).
RESULTS—Consistent with the initial study, we observed evi-
dence that the risk G allele of rs4430796 in intron 2 was
signiﬁcantly associated with type 2 diabetes (odds ratio 1.16 [95%
CI 1.05–1.29], P  0.0035, empirical P  0.0475). Furthermore,
the at-risk G allele was associated with earlier age at diagnosis in
the type 2 diabetic subjects (P  0.0228).
CONCLUSIONS—The result of this study provides evidence
that variants in the HNF1 region contribute to susceptibility to
type 2 diabetes in the Chinese population. Diabetes 58:1023–
1027, 2009
H
epatocyte nuclear factor 1 (HNF1, also
known as transcription factor [TCF]2), is a
homeodomain-containing transcription fac-
tor that functions as a homodimer or het-
erodimer with its homologous partner HNF1 (1).
HNF1 is widely expressed in a number of tissues
where it takes a vital role in embryonic development
and pancreatic cell formation and is involved in the
-cell transcription factor network (2,3). Heterozygous
mutation of the HNF1 gene was identiﬁed in an
autosomal dominant, early-onset subtype of diabetes
known as maturity-onset diabetes of the young type 5
(MODY5) in Caucasian, Japanese, and Chinese popula-
tions (4–6). It is well recognized that common variants
of genes that cause monogenic forms of diabetes may
also have a role in common type 2 diabetes susceptibil-
ity, such as P12A polymorphism in PPARG, E23K poly-
morphism in KCNJ11, and common variants in the
promoter region of HNF4A (7–9). Recently, single nu-
cleotide polymorphisms (SNPs) on HNF1 were identi-
ﬁed to be associated with type 2 diabetes in Finland,
Sweden, and Canada populations (10,11). The associa-
tion signals, which were separated by recombination
hot spots, were located on introns 2 (rs757210) and 6–8
(rs1008284 and rs3110641). Moreover, a genome-wide
association study on prostate cancer identiﬁed that the
G allele of rs7501939 and A allele of rs4430796 (both in
the intron 1–2 region) were associated with increased
risk of prostate cancer in Caucasians and reduced risk
of type 2 diabetes in Caucasians and Africans but not
Hong Kong Chinese (12). However, the study by
Holmkvist et al. (13) produced the conﬂicting results
that common variants in HNF1 did not predict future
risk of type 2 diabetes in two prospective studies. Thus,
extensive study, especially in other ethnic groups, will
improve our understanding of the role of HNF1 in type
2 diabetes predisposition. We therefore selected tagging
SNPs spanning the HNF1 gene and performed a case-
control study in a Chinese Han population.
RESEARCH DESIGN AND METHODS
All subjects were of eastern Chinese Han ancestry and resided in Shanghai. All
case subjects were from the 2001–2005 inpatient database of the Shanghai
Diabetes Institute and were diagnosed with type 2 diabetes by the 1999 World
Health Organization criteria (14). Type 1 diabetes and mitochondrial diabetes
were excluded (15). The control subjects were selected from the Shanghai
Diabetes Studies, a community-based epidemiological survey for diabetes
(16). The inclusion criteria for the control subjects were 1) age 40 years, 2)
normal glucose regulation conﬁrmed by a standard 75-g oral glucose tolerance
test (fasting plasma glucose 6.1 mmol/l and 2-h plasma glucose 7.8
mmol/l), and 3) absence of family history of diabetes stated on a standard
questionnaire. In the end, the study groups comprised 1,859 subjects with type
2 diabetes and 1,785 subjects with normal glucose regulation. The phenotypic
characteristics of the study group are described in Table 1.
This study was approved by the institutional review board of Shanghai Jiao
Tong University Afﬁliated Sixth People’s Hospital. Written informed consent
was obtained from each participant.
Anthropometric parameters such as height, weight, waist and hip
circumference, and blood pressure were measured as previously described
(16,17). For the case subjects, fasting and postprandial plasma glucose and
serum insulin were measured. For the control subjects, blood samples
were obtained at 0 and 120 min during the oral glucose tolerance test, and
plasma glucose and serum insulin levels were examined. Insulin resistance
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assessment (18).
Genotyping. We initially selected 20 SNPs spanning the HNF1 region,
including both 1) tagging SNPs selected from the HapMap Phase II Chinese
Han database that captured all common variants (minor allele frequency 0.1)
from 3 kb upstream to 1 kb downstream of the gene based on an r
2 of 0.7
and 2) SNPs previously reported to be associated with type 2 diabetes. SNPs
were genotyped by matrix-assisted laser desorption ionization–time of ﬂight
mass spectroscopy (MassARRAY Compact Analyzer, Sequenom, San Diego,
CA). Genotyping data underwent a series of quality-control checks, and
cleaned data were used in the further association analyses. Fifteen SNPs had
a call rate 95%, whereas ﬁve SNPs were excluded because of low genotyping
call rate (rs1016990, rs7407025, rs1008284, rs3110640, and rs11263755). SNPs
with Hardy-Weinberg equilibrium test P values 0.05 in the case or control
subjects were excluded. No SNP was excluded because of inconsistency with
Hardy-Weinberg expectations. The average reproducibility rate among 1,500
duplicate genotype pairs was 100%. The overall call rate for the remaining 15
SNPs was 99.1%.
Statistical methods. The Hardy-Weinberg equilibrium test was performed in
the case and control groups separately for each variant using 
2 test. Pairwise
linkage disequilibrium was computed from the combined data of case and
control subjects by calculating D and r
2 in Haploview (version 4.1) (19).
Sliding windows consisting of two or three adjacent SNPs were generated for
haplotype analyses using PLINK (version 0.99) (20). Allele, genotype, and
haplotype frequencies for case and control subjects were compared using the

2 test or Fisher’s exact test. Odds ratios (ORs) with 95% CIs were presented.
Correction of multiple testing was performed in Haploview through 10,000
permutations. Empirical P values of logistic regression analysis were calcu-
lated through 500 permutations that generated simulation data by randomly
shufﬂing case and control status. In the control group, continuous diabetes-
related traits were analyzed, and quantitative traits were transformed to
reduce skewness. All statistical analyses were performed by SAS (version 8.0;
SAS Institute, Cary, NC), unless otherwise speciﬁed. A two-tailed P value
0.05 was considered signiﬁcant. Considering a risk allele frequency of 20%
and an additive model, we had 80% power to detect an OR of 1.15 at the 0.05
level.
RESULTS
We examined 15 tagging SNPs spanning the HNF1
region. Figure 1 shows the pairwise linkage disequilib-
rium and haplotype block structure among these SNPs.
The association of single SNPs with type 2 diabetes risk
is shown in Table 2. Six of the 15 SNPs, including three
previously reported SNPs, had a nominal P  0.05.
Three previously reported SNPs (rs4430796, rs757210 in
intron 2, and rs3110641 in intron 8) were signiﬁcantly
associated with type 2 diabetes susceptibility (OR 1.13–
1.16, P  0.0035–0.0178). Three additional SNPs (two
SNPs in intron 8 and one in the 5 end of the gene
region) also showed nominal signiﬁcance (1.15–1.25,
P  0.0046–0.0178). Logistic regression analysis of type
2 diabetes with these six SNPs showed that the G allele
of rs4430796 and A allele of rs11656817 tended to confer
independent risks of type 2 diabetes (adjusted OR 1.135
and 1.211, P  0.0162 and 0.0203, respectively). How-
ever, after adjustment for multiple testing by permuta-
tion, only the risk G allele of rs4430796 (in intron 2)
showed signiﬁcantly associated increased risk of type 2
diabetes (OR 1.16 [95% CI 1.05–1.29], P  0.0035,
empirical P  0.0475). Logistic regression analysis
adjusting for age, sex, and BMI also indicated that the
association with SNP rs4430796 was statistically signif-
icant (1.18 [1.06–1.31], P  0.0025, empirical P  0.034).
Sliding window haplotype analysis found that windows
containing rs4430796 showed the strongest association
with type 2 diabetes, which merely conﬁrmed the results
of single-SNP association analysis (Figure S1 available
in an online appendix [http://diabetes.diabetesjournals.
org/cgi/content/full/db08-1064/DC1]).
Because rs4430796 exhibited strong association with
diabetes in our population, further analyses focused on
this SNP for diabetes-related traits. We ﬁrst treated age at
diagnosis as a quantitative trait and analyzed its associa-
tion with rs4430796 in the type 2 diabetic subjects. There
TABLE 2
Allele frequencies and association results for SNPs in the HNF1 gene
Position
(bp)
HNF1
region
Major/minor
allele
Risk
allele
Risk allele
frequency
OR (95% CI) PSNP Pgene
Adjusted
PSNP*
Case
subjects
Control
subjects
rs17626423 	3,492 5 T/C T 0.886 0.885 1.01 (0.88–1.17) 0.8804 1 0.4552
rs3760511 	1,438 5 C/A A 0.368 0.336 1.15 (1.04–1.27) 0.0046 0.0624 0.0117
rs4430796 6,836 Intron 2 A/G G 0.312 0.280 1.16 (1.05–1.29) 0.0035 0.0475 0.0025
rs757210 8,361 Intron 2 G/A A 0.289 0.264 1.13 (1.02–1.26) 0.0178 0.2129 0.6318
rs3744763 13,991 Intron 4 C/T C 0.557 0.545 1.05 (0.96–1.15) 0.3065 0.9874 0.5032
rs3786127 17,002 Intron 4 C/G C 0.837 0.834 1.02 (0.90–1.15) 0.7708 1 0.7296
rs2107131 18,187 Intron 4 C/T T 0.375 0.364 1.05 (0.95–1.15) 0.3403 0.9934 0.3711
rs12450628 22,455 Intron 4 C/T C 0.651 0.646 1.02 (0.93–1.12) 0.6989 1 0.8704
rs11649743 29,897 Intron 4 G/A A 0.328 0.323 1.02 (0.93–1.13) 0.6373 1 0.8719
rs2158254 39,381 Intron 5 G/A A 0.266 0.257 1.05 (0.94–1.16) 0.4075 0.9981 0.2062
rs2189303 44,771 Intron 7 C/T T 0.397 0.390 1.03 (0.94–1.13) 0.5362 1 0.9497
rs11656817 47,977 Intron 8 A/G A 0.916 0.898 1.25 (1.06–1.46) 0.0067 0.0873 0.0210
rs11868513 52,184 Intron 8 G/A G 0.721 0.719 1.01 (0.91–1.12) 0.8353 1 0.8193
rs1859211 53,504 Intron 8 A/G A 0.911 0.894 1.21 (1.03–1.41) 0.0178 0.2138 0.0344
rs3110641 57,459 Intron 8 C/T C 0.770 0.745 1.14 (1.03–1.27) 0.0139 0.1742 0.0307
*Adjusted for age, sex, and BMI.
TABLE 1
Clinical characteristics of the study subjects
Case
subjects
Control
subjects
n 1,859 1,785
Sex (male/female) 973/886 739/1,046
Ages (years) 61.16 
 12.63 57.37 
 12.33
BMI (kg/m
2) 24.08 
 3.53 23.63 
 4.23
Fasting plasma glucose (mmol/l) 13.04 
 5.19 4.99 
 0.50
Age at diagnosis (years) 54.10 
 11.85 —
Data are n or means 
 SD.
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1024 DIABETES, VOL. 58, APRIL 2009was evidence that the G allele of rs4430796 was associated
with younger age at diagnosis (52.40 
 11.18 years for G/G,
53.94 
 11.85 years for G/A, and 54.61 
 11.97 years for
A/A, P  0.0228). When treating age at diagnosis as a
dichotomous trait to stratify the type 2 diabetic patients
and comparing the allele frequencies of rs4430796 with
control subjects, we also found that the association signal
was slightly stronger in the early-onset (age of diagnosis
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FIG. 1. Linkage disequilibrium patterns of the 15 typed SNPs in the Chinese population.
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DIABETES, VOL. 58, APRIL 2009 102545 years) subgroups (OR 1.27 [95% CI 1.07–1.49], P 
0.0051, Table 3).
In subjects with normal glucose regulation, this SNP
was not associated with plasma glucose levels; adipos-
ity-related anthropometrics such as BMI, waist circum-
ference, and waist-to-hip ratio; lipid proﬁle; insulin
sensitivity; or insulin secretion (supplementary Table
S1).
DISCUSSION
We replicated previous ﬁndings that a SNP (rs4430796) in
intron 2 of HNF1 was signiﬁcantly associated with type 2
diabetes in our Chinese population. Our results are
consistent with those reported by Gudmundsson et al.
(12), and the effect size of the at-risk G allele for
rs4430796 in our Chinese subjects (OR 1.16) is quite
similar to that determined by the DECODE ﬁndings (for
the G allele, overall OR 1.10). Notably, the allele fre-
quency for the SNP rs4430796 is quite different between
different ethnic groups. The at-risk G allele for
rs4430796 had a frequency of 0.25–0.30 in the Chinese
population but a frequency of 0.47–0.54 and 0.70–0.73 in
Caucasians and West Africans, respectively (11,12).
Although the minor G allele identiﬁed in the Chinese
and Caucasian populations is the major allele in West
Africans, this allele showed the same direction of its
effect for type 2 diabetes. rs4430796 was not signiﬁ-
cantly associated with type 2 diabetes in Hong Kong
Chinese, although the effect sizes between the Shanghai
and Hong Kong samples were similar (for the risk G
allele, OR 1.16 and 1.12, respectively) and in the same
direction. One potential explanation for the discrepancy
between the current ﬁndings and the results in the Hong
Kong population is the difference in the control ascer-
tainment. The Shanghai control subjects were 40 years
of age and had measurements for both fasting plasma
glucose and 2-h plasma glucose. In contrast to the individuals
of our study, the Hong Kong control subjects were only
tested for fasting plasma glucose. In addition, more than
one-third of these control subjects were adolescents. All of
these considerations raise the possibility of misclassiﬁcation
in the Hong Kong control samples; consequently, the effect
size may be underestimated.
In the study by Winckler et al. (11), the authors observed
that other SNPs in intron 2 (rs757210) and intron 8
(rs3110641) were associated with type 2 diabetes in a large
Caucasian sample (combined OR 1.12 and 1.10, P  5 
10
	6 and 0.0006, respectively). SNP rs757210 is correlated
with rs4430796 ( D 0.87 and r
2  0.71 in our popula-
tion). In the present study, although neither of the two
SNPs reached signiﬁcance after a correction for multiple
testing, these two SNPs showed a similar trend in the same
direction in our samples. In the study by Holmkvist et al.
(13), the three previously reported SNPs (including
rs1008284, rs3110641, and rs757210) did not predict future
risk. However, our study suggests that the strongest effect
for type 2 diabetes susceptibility was at rs4430796, and
further study to follow up and replicate the association is
still necessary.
Our study is the ﬁrst to demonstrate that the at-risk G
allele for rs4430796 is also associated with earlier onset of
type 2 diabetes. Interestingly, previous studies have pro-
vided evidence that common variants in the MODY1 gene
(HNF4A) also associated with type 2 diabetes and age at
diagnosis (21,22). Nevertheless, rs4430796 was in the
intron region of HNF1, with no obvious functional effect
reported; thus, we cannot exclude the possibility that
other, as yet unknown or untyped, SNPs in linkage dis-
equilibrium with rs4430796 may be the causal variants.
There are several limitations of this study. First, al-
though the age of diagnosis of diabetes was determined by
physician-documented medical records, we cannot ex-
clude the possibility that the case subjects had an earlier
age of onset. Second, the SNPs that we successfully
genotyped can only capture 60% of common SNPs in the
HNF1 gene region under the threshold of r
2  0.7 based
on phase 3 HapMap Chinese data. It may be inevitable that
we miss some common variants in this region that con-
tribute to diabetes.
In summary, our data replicated the previous ﬁnding by
Gudmundsson et al. (12) and support the notion that
genetic variation in the HNF1 is associated with type 2
diabetes. Further studies in other populations and of more
SNPs at this gene will be required to further elucidate the
role of HNF1 variation in the pathogenesis of type 2
diabetes.
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